Edward Giovannucci

Author PubWeight™ 557.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 50.94
2 Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007 21.18
3 Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008 17.65
4 Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006 10.95
5 Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 2013 7.72
6 Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med 2012 7.47
7 Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007 6.99
8 Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005 5.95
9 Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 2003 4.40
10 Comparison of risk factors for colon and rectal cancer. Int J Cancer 2004 4.03
11 Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 2010 4.01
12 Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst 2006 3.96
13 Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 2012 3.67
14 A prospective study of aspirin use and the risk of pancreatic cancer in women. J Natl Cancer Inst 2004 3.49
15 Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol 2006 3.41
16 Periodontal disease, tooth loss, and cancer risk in male health professionals: a prospective cohort study. Lancet Oncol 2008 3.23
17 Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005 3.22
18 Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 2004 3.18
19 A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006 3.13
20 Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 2004 3.10
21 A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res 2007 3.08
22 Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol 2010 3.03
23 Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. J Natl Cancer Inst 2002 3.03
24 Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality. Crit Care Med 2012 2.97
25 Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst 2011 2.85
26 Colorectal cancer: a tale of two sides or a continuum? Gut 2012 2.85
27 Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 2007 2.83
28 A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment. Cancer Discov 2011 2.77
29 Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA 2005 2.76
30 Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer 2009 2.67
31 Smoking and prostate cancer survival and recurrence. JAMA 2011 2.63
32 Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst 2004 2.54
33 Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol 2007 2.52
34 Variation in KLK genes, prostate-specific antigen and risk of prostate cancer. Nat Genet 2008 2.45
35 Association of low serum 25-hydroxyvitamin D levels and mortality in the critically ill. Crit Care Med 2011 2.45
36 Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol 2011 2.42
37 A prospective study of periodontal disease and pancreatic cancer in US male health professionals. J Natl Cancer Inst 2007 2.40
38 Association of low serum 25-hydroxyvitamin D levels and sepsis in the critically ill. Crit Care Med 2014 2.38
39 Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 2008 2.33
40 Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer. JAMA 2011 2.28
41 Aspirin use and risk of colorectal cancer according to BRAF mutation status. JAMA 2013 2.26
42 A prospective study of risk factors for erectile dysfunction. J Urol 2006 2.25
43 A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 2004 2.22
44 Association between prehospital vitamin D status and hospital-acquired bloodstream infections. Am J Clin Nutr 2013 2.21
45 On the epidemiology of influenza. Virol J 2008 2.17
46 A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2005 2.15
47 Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. Am J Epidemiol 2012 2.07
48 Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol 2005 2.01
49 Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study. J Clin Oncol 2009 2.01
50 Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006 2.00
51 Manganese superoxide dismutase polymorphism, prediagnostic antioxidant status, and risk of clinical significant prostate cancer. Cancer Res 2005 1.98
52 Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk. Hum Mol Genet 2008 1.96
53 Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol 2013 1.95
54 Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS One 2010 1.91
55 Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010 1.90
56 Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet 2013 1.85
57 Gestational vitamin D and the risk of multiple sclerosis in offspring. Ann Neurol 2011 1.85
58 Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in U.S. men. Urology 2002 1.83
59 The correlation between metabolic syndrome and prostatic diseases. Eur Urol 2011 1.83
60 Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility. Proc Natl Acad Sci U S A 2009 1.81
61 Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst 2007 1.80
62 Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiol Biomarkers Prev 2005 1.80
63 Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J Natl Cancer Inst 2012 1.79
64 Association of low serum 25-hydroxyvitamin D levels and acute kidney injury in the critically ill. Crit Care Med 2012 1.78
65 Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res 2005 1.77
66 A review of the relationship between tooth loss, periodontal disease, and cancer. Cancer Causes Control 2008 1.76
67 A prospective study of statin drug use and lower urinary tract symptoms in older men. Am J Epidemiol 2013 1.75
68 Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. Int J Cancer 2009 1.74
69 Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. Am J Clin Nutr 2002 1.74
70 Major dietary patterns and the risk of colorectal cancer in women. Arch Intern Med 2003 1.74
71 A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomarkers Prev 2003 1.73
72 Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 2006 1.73
73 Ejaculation frequency and subsequent risk of prostate cancer. JAMA 2004 1.71
74 Association between plasma cholesterol and prostate cancer in the PSA era. Int J Cancer 2008 1.70
75 Calcium and dairy food intakes are inversely associated with colorectal cancer risk in the Cohort of Swedish Men. Am J Clin Nutr 2006 1.69
76 How many molecular subtypes? Implications of the unique tumor principle in personalized medicine. Expert Rev Mol Diagn 2012 1.66
77 The Mediterranean and Dietary Approaches to Stop Hypertension (DASH) diets and colorectal cancer. Am J Clin Nutr 2010 1.66
78 Joint association of glycemic load and alcohol intake with type 2 diabetes incidence in women. Am J Clin Nutr 2011 1.63
79 Methionine and vitamin B6 intake and risk of pancreatic cancer: a prospective study of Swedish women and men. Gastroenterology 2006 1.62
80 Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies. Cancer Prev Res (Phila) 2011 1.62
81 Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol 2002 1.61
82 Determinants of plasma 25-hydroxyvitamin D and development of prediction models in three US cohorts. Br J Nutr 2012 1.59
83 Eating patterns and type 2 diabetes risk in men: breakfast omission, eating frequency, and snacking. Am J Clin Nutr 2012 1.58
84 Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res 2012 1.58
85 Dietary marine n-3 fatty acids in relation to risk of distal colorectal adenoma in women. Cancer Epidemiol Biomarkers Prev 2005 1.56
86 Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer. Gut 2009 1.54
87 Smoking and aggressive prostate cancer: a review of the epidemiologic evidence. Cancer Causes Control 2009 1.53
88 Cod liver oil, vitamin A toxicity, frequent respiratory infections, and the vitamin D deficiency epidemic. Ann Otol Rhinol Laryngol 2008 1.53
89 Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk. Prostate 2007 1.52
90 The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer. J Steroid Biochem Mol Biol 2005 1.51
91 Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008 1.51
92 Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers. Cancer 2010 1.48
93 Dietary patterns and risk of prostate cancer in U.S. men. Cancer Epidemiol Biomarkers Prev 2006 1.47
94 Dietary patterns and pancreatic cancer risk in men and women. J Natl Cancer Inst 2005 1.46
95 Folate intake and risk of colorectal cancer and adenoma: modification by time. Am J Clin Nutr 2011 1.45
96 DNA methylation, field effects, and colorectal cancer. J Natl Cancer Inst 2005 1.44
97 Physical activity, sedentary behavior, and leukocyte telomere length in women. Am J Epidemiol 2012 1.43
98 Plasma levels of nitrate and risk of prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2013 1.42
99 Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J Clin Oncol 2008 1.42
100 Dietary meat, dairy products, fat, and cholesterol and pancreatic cancer risk in a prospective study. Am J Epidemiol 2003 1.42
101 Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3. PLoS One 2011 1.41
102 Peptic ulcer disease and the risk of bladder cancer in a prospective study of male health professionals. Cancer Epidemiol Biomarkers Prev 2004 1.40
103 Fruit and vegetable consumption and colorectal adenomas in the Nurses' Health Study. Cancer Res 2006 1.39
104 Vitamin D receptor protein expression in tumor tissue and prostate cancer progression. J Clin Oncol 2011 1.39
105 Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prev 2006 1.39
106 Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2004 1.38
107 Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival. J Clin Oncol 2010 1.37
108 Dietary glycemic load, carbohydrate, sugar, and colorectal cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2005 1.37
109 Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies. J Natl Cancer Inst 2007 1.37
110 Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diabetes Care 2005 1.36
111 Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women. J Natl Cancer Inst 2005 1.36
112 Dietary sugar, glycemic load, and pancreatic cancer risk in a prospective study. J Natl Cancer Inst 2002 1.35
113 Fatty acids and risk of prostate cancer in a nested case-control study in male smokers. Cancer Epidemiol Biomarkers Prev 2003 1.35
114 Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III). Prostate 2005 1.34
115 Genome-wide association study identifies multiple loci associated with bladder cancer risk. Hum Mol Genet 2013 1.34
116 Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era. Cancer Causes Control 2005 1.33
117 Prospective weight change and colon cancer risk in male US health professionals. Int J Cancer 2008 1.33
118 Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 2005 1.33
119 Fruits, vegetables and lung cancer: a pooled analysis of cohort studies. Int J Cancer 2003 1.32
120 Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school-age children: a randomized, double-blind, placebo-controlled feasibility trial. Am J Clin Nutr 2012 1.31
121 Dietary patterns and risk of colon cancer and adenoma in a cohort of men (United States). Cancer Causes Control 2004 1.30
122 Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer. J Natl Cancer Inst 2005 1.30
123 Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of beta-catenin in prostate cancer. Lab Invest 2008 1.30
124 Gonorrhea, syphilis, clinical prostatitis, and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006 1.29
125 Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev 2012 1.29
126 Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health And Nutrition Examination Survey. BJU Int 2005 1.29
127 A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma. Am J Clin Nutr 2009 1.28
128 Fruit and vegetable consumption, intake of micronutrients, and benign prostatic hyperplasia in US men. Am J Clin Nutr 2007 1.28
129 Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2007 1.28
130 C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women. Cancer Epidemiol Biomarkers Prev 2006 1.27
131 Intakes of vitamins A, C and E and folate and multivitamins and lung cancer: a pooled analysis of 8 prospective studies. Int J Cancer 2006 1.26
132 Hormonal profile of diabetic men and the potential link to prostate cancer. Cancer Causes Control 2008 1.26
133 A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer 2011 1.25
134 Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One 2011 1.25
135 Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies. Int J Cancer 2009 1.24
136 The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients. Cancer 2002 1.24
137 Are findings from studies of obesity and prostate cancer really in conflict? Cancer Causes Control 2006 1.24
138 Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level. J Natl Cancer Inst 2012 1.24
139 Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer. Cancer Causes Control 2010 1.22
140 Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies. Am J Clin Nutr 2012 1.21
141 Diabetes and colorectal cancer incidence in the cohort of Swedish men. Diabetes Care 2005 1.21
142 Folate intake and pancreatic cancer incidence: a prospective study of Swedish women and men. J Natl Cancer Inst 2006 1.21
143 Dietary glycemic load and risk of colorectal cancer in the Women's Health Study. J Natl Cancer Inst 2004 1.19
144 Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study. J Natl Cancer Inst 2012 1.19
145 Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2004 1.19
146 Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies. Cancer Epidemiol Biomarkers Prev 2009 1.19
147 A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians. Hum Mol Genet 2010 1.18
148 Dietary carotenoids and risk of lung cancer in a pooled analysis of seven cohort studies. Cancer Epidemiol Biomarkers Prev 2004 1.17
149 Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. BMC Med 2014 1.17
150 Meat mutagens and risk of distal colon adenoma in a cohort of U.S. men. Cancer Epidemiol Biomarkers Prev 2006 1.17
151 Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer. Cancer Epidemiol Biomarkers Prev 2007 1.17
152 Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III). Urology 2007 1.17
153 MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers. Cancer Causes Control 2010 1.16
154 Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States men. J Urol 2012 1.16
155 Aspirin use in relation to risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2002 1.16
156 Intakes of fruits, vegetables, vitamins A, C, and E, and carotenoids and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev 2006 1.16
157 Fructose, glycemic load, and quantity and quality of carbohydrate in relation to plasma C-peptide concentrations in US women. Am J Clin Nutr 2004 1.15
158 Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence. Int J Cancer 2006 1.15
159 Diet and cancer prevention: the roles of observation and experimentation. Nat Rev Cancer 2008 1.13
160 Manganese superoxide dismutase (MnSOD) gene polymorphism, interactions with carotenoid levels and prostate cancer risk. Carcinogenesis 2008 1.13
161 PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). Carcinogenesis 2009 1.13
162 Effects of sample attrition in a longitudinal study of the association between alcohol intake and all-cause mortality. Addiction 2008 1.13
163 Evidence for a U-shaped relationship between prehospital vitamin D status and mortality: a cohort study. J Clin Endocrinol Metab 2014 1.12
164 Body mass index, physical activity, and risk of multiple myeloma. Cancer Epidemiol Biomarkers Prev 2007 1.12
165 Intakes of fruit, vegetables, and carotenoids and renal cell cancer risk: a pooled analysis of 13 prospective studies. Cancer Epidemiol Biomarkers Prev 2009 1.12
166 Alcohol intake, drinking patterns, and risk of prostate cancer in a large prospective cohort study. Am J Epidemiol 2004 1.12
167 Nutrient biomarkers are not always simple markers of nutrient intake. Am J Clin Nutr 2013 1.12
168 Intake of folate and related nutrients in relation to risk of epithelial ovarian cancer. Am J Epidemiol 2006 1.12
169 Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. J Natl Cancer Inst 2014 1.11
170 Acne and risk of prostate cancer. Int J Cancer 2007 1.11
171 Leisure-time physical activity patterns and risk of colon cancer in women. Int J Cancer 2007 1.10
172 Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 2006 1.10
173 Prevalence and correlates of vitamin D status in African American men. BMC Public Health 2009 1.10
174 Association between sex hormones and colorectal cancer risk in men and women. Clin Gastroenterol Hepatol 2012 1.09
175 Dietary fat and cancer. Am J Med 2002 1.09
176 Folic acid and prevention of colorectal adenomas: a combined analysis of randomized clinical trials. Int J Cancer 2011 1.09
177 Gleason grade progression is uncommon. Cancer Res 2013 1.09
178 Dietary folate intake and incidence of ovarian cancer: the Swedish Mammography Cohort. J Natl Cancer Inst 2004 1.08
179 Meat intake and bladder cancer risk in 2 prospective cohort studies. Am J Clin Nutr 2006 1.08
180 Eating patterns and type 2 diabetes risk in older women: breakfast consumption and eating frequency. Am J Clin Nutr 2013 1.08
181 A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification. Am J Epidemiol 2013 1.08
182 Plasma C-peptide is inversely associated with calcium intake in women and with plasma 25-hydroxy vitamin D in men. J Nutr 2009 1.07
183 Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD). Sci Transl Med 2014 1.07
184 Whole milk intake is associated with prostate cancer-specific mortality among U.S. male physicians. J Nutr 2012 1.07
185 Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care 2002 1.07
186 Novel application of structural equation modeling to correlation structure analysis of CpG island methylation in colorectal cancer. Am J Pathol 2010 1.07
187 Belief beyond the evidence: using the proposed effect of breakfast on obesity to show 2 practices that distort scientific evidence. Am J Clin Nutr 2014 1.07
188 Coffee consumption and risk of endometrial cancer: findings from a large up-to-date meta-analysis. Int J Cancer 2012 1.07
189 APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma. Cancer Epidemiol Biomarkers Prev 2005 1.06
190 Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status. Cancer Res 2013 1.06
191 Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol 2012 1.05
192 Dietary intake of vitamin D during adolescence and risk of multiple sclerosis. J Neurol 2010 1.04
193 A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. J Clin Endocrinol Metab 2010 1.04
194 Association between plasma 25-OH vitamin D and testosterone levels in men. Clin Endocrinol (Oxf) 2012 1.04
195 Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2013 1.04
196 Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study. Cancer Res 2011 1.03
197 Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium. Cancer Epidemiol Biomarkers Prev 2013 1.03
198 Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death. Cancer Discov 2013 1.03
199 Flavonoid intake and colorectal cancer risk in men and women. Am J Epidemiol 2006 1.02
200 Dietary carotenoids and risk of colorectal cancer in a pooled analysis of 11 cohort studies. Am J Epidemiol 2006 1.02
201 Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2011 1.02
202 Sexually transmitted infections, prostatitis, ejaculation frequency, and the odds of lower urinary tract symptoms. Am J Epidemiol 2005 1.02
203 B vitamins, methionine and alcohol intake and risk of colon cancer in relation to BRAF mutation and CpG island methylator phenotype (CIMP). PLoS One 2011 1.01
204 The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918-1919 influenza pandemic in the United States. Dermatoendocrinol 2009 1.01
205 Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3). Hum Mol Genet 2009 1.01
206 Pre-hospital vitamin D concentration, mortality, and bloodstream infection in a hospitalized patient population. Am J Med 2013 1.01
207 Dietary fatty acid intake and prostate cancer survival in Örebro County, Sweden. Am J Epidemiol 2012 1.01
208 Total fluid intake and use of individual beverages and risk of renal cell cancer in two large cohorts. Cancer Epidemiol Biomarkers Prev 2006 1.01
209 A prospective study of dietary folate intake and risk of colorectal cancer: modification by caffeine intake and cigarette smoking. Cancer Epidemiol Biomarkers Prev 2005 1.00
210 Interrelation of energy intake, body size, and physical activity with prostate cancer in a large prospective cohort study. Cancer Res 2003 0.99
211 Prostate cancer association studies: pitfalls and solutions to cancer misclassification in the PSA era. J Cell Biochem 2004 0.99
212 Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma. Cancer Epidemiol Biomarkers Prev 2009 0.98
213 Dietary iron, zinc, and calcium and the risk of lung cancer. Epidemiology 2005 0.98
214 Commentary: Lifestyle factors and colorectal cancer microsatellite instability--molecular pathological epidemiology science, based on unique tumour principle. Int J Epidemiol 2012 0.98
215 Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era. Prostate 2008 0.98
216 Glycaemic index and glycaemic load in relation to risk of diabetes-related cancers: a meta-analysis. Br J Nutr 2012 0.97
217 Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study. Carcinogenesis 2004 0.97
218 A prospective analysis of body size during childhood, adolescence, and adulthood and risk of non-Hodgkin lymphoma. Cancer Prev Res (Phila) 2013 0.97
219 A pooled analysis of smoking and colorectal cancer: timing of exposure and interactions with environmental factors. Cancer Epidemiol Biomarkers Prev 2012 0.97
220 CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 2009 0.97
221 Calcium, vitamin D and colorectal cancer chemoprevention. Best Pract Res Clin Gastroenterol 2011 0.97
222 Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Cancer Epidemiol Biomarkers Prev 2011 0.96
223 A prospective cohort study of coffee consumption and risk of endometrial cancer over a 26-year follow-up. Cancer Epidemiol Biomarkers Prev 2011 0.96
224 Can vitamin D reduce total mortality? Arch Intern Med 2007 0.96
225 Fiber intake and incidence of colorectal cancer among 76,947 women and 47,279 men. Cancer Epidemiol Biomarkers Prev 2005 0.96
226 Sex hormones and colorectal cancer: what have we learned so far? J Natl Cancer Inst 2010 0.96
227 Expression profiling of archival tumors for long-term health studies. Clin Cancer Res 2012 0.96
228 Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer. Cancer Epidemiol Biomarkers Prev 2013 0.96
229 Statin use and colorectal cancer risk according to molecular subtypes in two large prospective cohort studies. Cancer Prev Res (Phila) 2011 0.95
230 Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993-2004. Int J Cancer 2011 0.95
231 Body fatness during childhood and adolescence, adult height, and risk of colorectal adenoma in women. Cancer Prev Res (Phila) 2011 0.95
232 Intakes of coffee, tea, milk, soda and juice and renal cell cancer in a pooled analysis of 13 prospective studies. Int J Cancer 2007 0.95
233 Replication of five prostate cancer loci identified in an Asian population--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Cancer Epidemiol Biomarkers Prev 2011 0.95
234 Dietary fat and risk of lung cancer in a pooled analysis of prospective studies. Cancer Epidemiol Biomarkers Prev 2002 0.95
235 Prospective study of selenium levels in toenails and risk of coronary heart disease in men. Am J Epidemiol 2003 0.95
236 Vitamin D: epidemiology of cardiovascular risks and events. Best Pract Res Clin Endocrinol Metab 2011 0.95
237 Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies. Br J Haematol 2014 0.95
238 Expanding roles of vitamin D. J Clin Endocrinol Metab 2009 0.95
239 Dietary carbohydrate, glycemic index, and glycemic load in relation to risk of colorectal cancer in women. Am J Epidemiol 2006 0.94
240 O6-methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the Nurses' Health Study and Physicians' Health Study (United States). Cancer Causes Control 2006 0.94
241 Coffee, tea, caffeine intake, and risk of adult glioma in three prospective cohort studies. Cancer Epidemiol Biomarkers Prev 2010 0.94
242 Re: Heme iron, zinc, alcohol consumption, and risk of colon cancer. J Natl Cancer Inst 2005 0.94
243 Coffee consumption and incidence of colorectal cancer in two prospective cohort studies of Swedish women and men. Am J Epidemiol 2006 0.93
244 Dietary carotenoids and the risk of invasive breast cancer. Int J Cancer 2009 0.93
245 Shortcomings of vitamin D-based model simulations of seasonal influenza. PLoS One 2011 0.93
246 Dietary insulin load, dietary insulin index, and colorectal cancer. Cancer Epidemiol Biomarkers Prev 2010 0.92
247 Dietary factors and biomarkers involved in the methylenetetrahydrofolate reductase genotype-colorectal adenoma pathway. Gastroenterology 2006 0.92
248 Prospective study of fruits and vegetables and risk of oral premalignant lesions in men. Am J Epidemiol 2006 0.92
249 Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006 0.92
250 Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case-control studies. Cancer Causes Control 2012 0.92
251 Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study. Int J Cancer 2007 0.92
252 A prospective cohort study of red wine consumption and risk of prostate cancer. Int J Cancer 2007 0.92
253 Alcohol intake and colorectal cancer: a comparison of approaches for including repeated measures of alcohol consumption. Epidemiology 2008 0.92
254 Vitamin B6 intake, alcohol consumption, and colorectal cancer: a longitudinal population-based cohort of women. Gastroenterology 2005 0.92
255 Prospective study of alcohol consumption and risk of oral premalignant lesions in men. Cancer Epidemiol Biomarkers Prev 2006 0.92
256 Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 2007 0.92
257 A prospective study of lower urinary tract symptoms and erectile dysfunction. J Urol 2008 0.91
258 Intakes of vitamins A, C, and E and use of multiple vitamin supplements and risk of colon cancer: a pooled analysis of prospective cohort studies. Cancer Causes Control 2010 0.91
259 The joint association of eating frequency and diet quality with colorectal cancer risk in the Health Professionals Follow-up Study. Am J Epidemiol 2012 0.91
260 Choline and betaine intake and the risk of colorectal cancer in men. Cancer Epidemiol Biomarkers Prev 2010 0.90
261 Calcium plus vitamin D and the risk of colorectal cancer. N Engl J Med 2006 0.90
262 Viral infections and lower urinary tract symptoms in the third national health and nutrition examination survey. J Urol 2007 0.89
263 Intake of fruits and vegetables, carotenoids, folate, and vitamins A, C, E and risk of bladder cancer among women (United States). Cancer Causes Control 2005 0.89
264 Dietary insulin index and insulin load in relation to biomarkers of glycemic control, plasma lipids, and inflammation markers. Am J Clin Nutr 2011 0.89
265 Prospective study of plasma vitamin B6 and risk of colorectal cancer in men. Cancer Epidemiol Biomarkers Prev 2009 0.89
266 Coffee consumption and stomach cancer risk in a cohort of Swedish women. Int J Cancer 2006 0.89
267 Does prostate-specific antigen screening influence the results of studies of tomatoes, lycopene, and prostate cancer risk? J Natl Cancer Inst 2007 0.89
268 Reexamination of total fluid intake and bladder cancer in the Health Professionals Follow-up Study Cohort. Am J Epidemiol 2012 0.88
269 A dietary pattern that is associated with C-peptide and risk of colorectal cancer in women. Cancer Causes Control 2012 0.88
270 Epoxide hydrolase and CYP2C9 polymorphisms, cigarette smoking, and risk of colorectal carcinoma in the Nurses' Health Study and the Physicians' Health Study. Mol Carcinog 2005 0.88
271 Vitamin B6 and colorectal cancer: current evidence and future directions. World J Gastroenterol 2013 0.87
272 XRCC2 and XRCC3 polymorphisms are not associated with risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev 2004 0.87
273 One-carbon metabolism factors and leukocyte telomere length. Am J Clin Nutr 2013 0.87
274 Vitamin D status and cancer incidence and mortality. Adv Exp Med Biol 2014 0.87
275 Tomato products, lycopene, and prostate cancer risk. Urol Clin North Am 2002 0.86
276 Common genetic variation of the calcium-sensing receptor and lethal prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2012 0.86
277 Interactions between plasma levels of 25-hydroxyvitamin D, insulin-like growth factor (IGF)-1 and C-peptide with risk of colorectal cancer. PLoS One 2011 0.86
278 Immunohistochemical expression of BRCA1 and lethal prostate cancer. Cancer Res 2010 0.86
279 Weight training, aerobic physical activities, and long-term waist circumference change in men. Obesity (Silver Spring) 2014 0.86
280 Dairy intake and 1,25-dihydroxyvitamin D levels in men at high risk for prostate cancer. Cancer Causes Control 2009 0.85
281 Is the androgen receptor CAG repeat length significant for prostate cancer? Cancer Epidemiol Biomarkers Prev 2002 0.85
282 Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality. Prostate 2011 0.85
283 Genetic predisposition to higher body mass index or type 2 diabetes and leukocyte telomere length in the Nurses' Health Study. PLoS One 2013 0.85
284 History of peptic ulcer disease and pancreatic cancer risk in men. Gastroenterology 2009 0.85
285 Meat consumption, heterocyclic amines, NAT2, and the risk of breast cancer. Nutr Cancer 2009 0.85
286 Are dietary choline and betaine intakes determinants of total homocysteine concentration? Am J Clin Nutr 2010 0.85
287 Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). Int J Cancer 2013 0.84
288 Postmenopausal hormone therapy is associated with a reduced risk of colorectal cancer lacking CDKN1A expression. Cancer Res 2012 0.84
289 Plasma vitamin D biomarkers and leukocyte telomere length. Am J Epidemiol 2013 0.84
290 Sequence variants of elaC homolog 2 (Escherichia coli) (ELAC2) gene and susceptibility to prostate cancer in the Health Professionals Follow-Up Study. Carcinogenesis 2008 0.83
291 Meat mutagens and breast cancer in postmenopausal women--a cohort analysis. Cancer Epidemiol Biomarkers Prev 2010 0.83
292 Prospective study of vitamins C, E, and A and carotenoids and risk of oral premalignant lesions in men. Int J Cancer 2007 0.83
293 Folate intake and risk of pancreatic cancer: pooled analysis of prospective cohort studies. J Natl Cancer Inst 2011 0.83
294 Genetic variation in sex-steroid receptors and synthesizing enzymes and colorectal cancer risk in women. Cancer Causes Control 2010 0.83
295 Effect of combined folic acid, vitamin B(6), and vitamin B(12) on colorectal adenoma. J Natl Cancer Inst 2012 0.83
296 Total antioxidant capacity intake and colorectal cancer risk in the Health Professionals Follow-up Study. Cancer Causes Control 2010 0.83
297 Dietary intakes of red meat, poultry, and fish during high school and risk of colorectal adenomas in women. Am J Epidemiol 2013 0.82
298 Ultraviolet index and racial differences in prostate cancer incidence and mortality. Cancer 2013 0.82
299 Folate intake and stomach cancer incidence in a prospective cohort of Swedish women. Cancer Epidemiol Biomarkers Prev 2006 0.82
300 Association of IGF-1 and IGFBP-3 with lower urinary tract symptoms in the third national health and nutrition examination survey. Prostate 2007 0.82
301 Vitamin and carotenoid intake and risk of squamous cell carcinoma of the skin. Int J Cancer 2003 0.82
302 Prospective study of meat intake and dietary nitrates, nitrites, and nitrosamines and risk of adult glioma. Am J Clin Nutr 2009 0.82
303 Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study. Cancer Epidemiol Biomarkers Prev 2008 0.82
304 Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol 2012 0.82
305 Polymorphism in the thymidylate synthase promoter enhancer region and risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2004 0.81
306 α-Methylacyl-CoA racemase expression and lethal prostate cancer in the Physicians' Health Study and Health Professionals Follow-up Study. Prostate 2011 0.81
307 Association between the Met326Ile polymorphism of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase and prostate cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev 2003 0.81
308 Carotenoid intake and risk of colorectal adenomas in a cohort of male health professionals. Cancer Causes Control 2013 0.81
309 Prospective study of effect modification by Toll-like receptor 4 variation on the association between Trichomonas vaginalis serostatus and prostate cancer. Cancer Causes Control 2012 0.81
310 Dietary acrylamide and risk of prostate cancer. Int J Cancer 2011 0.80
311 A prospective study of magnesium and iron intake and pancreatic cancer in men. Am J Epidemiol 2009 0.80
312 Dietary insulin load, dietary insulin index, and risk of pancreatic cancer. Am J Clin Nutr 2011 0.80
313 Thiazide diuretics and the risk of gallbladder disease requiring surgery in women. Arch Intern Med 2005 0.80
314 Longitudinal and secular trends in dietary supplement use: Nurses' Health Study and Health Professionals Follow-Up Study, 1986-2006. J Acad Nutr Diet 2013 0.80
315 Association between serum concentrations of micronutrients and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey. Urology 2004 0.79
316 Dietary patterns during high school and risk of colorectal adenoma in a cohort of middle-aged women. Int J Cancer 2013 0.79
317 Alcoholic beverage consumption and gastric cancer risk: a prospective population-based study in women. Int J Cancer 2007 0.79
318 Application of a novel score test for genetic association incorporating gene-gene interaction suggests functionality for prostate cancer susceptibility regions. Hum Hered 2011 0.79
319 Ogino et Al. Respond to "the 21st century epidemiologist". Am J Epidemiol 2012 0.79
320 Vitamin D, how much is enough and how much is too much? Public Health Nutr 2011 0.78
321 Fiber from fruit and colorectal neoplasia. Cancer Epidemiol Biomarkers Prev 2004 0.78
322 Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 2011 0.78
323 Physical activity and risk of endometrial adenocarcinoma in the Nurses' Health Study. Int J Cancer 2013 0.78
324 Association between genetic polymorphisms of macrophage scavenger receptor 1 gene and risk of prostate cancer in the health professionals follow-up study. Cancer Epidemiol Biomarkers Prev 2008 0.78
325 A large cohort study of nonsteroidal anti-inflammatory drugs and renal cell carcinoma incidence in the National Institutes of Health-AARP Diet and Health Study. Cancer Causes Control 2013 0.77
326 Commentary. On the epidemiology of influenza: reply to Radonovich et al. Virol J 2009 0.77
327 Adolescent dietary vitamin D and sun exposure in relation to benign breast disease. Cancer Causes Control 2015 0.77
328 Seasonal variation in expression of markers in the vitamin D pathway in prostate tissue. Cancer Causes Control 2012 0.77
329 ATAAA repeat upstream of glutathione S-transferase P1 and prostate cancer risk. Urology 2002 0.76
330 Fluid intake and risk of bladder cancer in the Nurses' Health Studies. Int J Cancer 2014 0.76
331 Prediagnostic plasma vitamin B6 (pyridoxal 5'-phosphate) and survival in patients with colorectal cancer. Cancer Causes Control 2013 0.76
332 Passive smoking and pancreatic cancer in women: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 2009 0.76
333 Height and the survival of prostate cancer patients. Cancer Epidemiol Biomarkers Prev 2003 0.76
334 Cholecalciferol treatment in older patients with isolated systolic hypertension. JAMA Intern Med 2013 0.75
335 Reported behavior of eating anything at anytime and risk of colorectal cancer in women. Int J Cancer 2011 0.75
336 Re: "a prospective study of statin drug use and lower urinary tract symptoms in older men". Author reply. Am J Epidemiol 2014 0.75
337 Re: Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. J Urol 2004 0.75
338 Coffee intake and incidence of erectile dysfunction. Am J Epidemiol 2017 0.75
339 Interactions Between Genome-Wide Significant Genetic Variants and Circulating Concentrations of 25-Hydroxyvitamin D in Relation to Prostate Cancer Risk in the National Cancer Institute BPC3. Am J Epidemiol 2017 0.75
340 Exposure to polychlorinated biphenyls and prostate cancer: population-based prospective cohort and experimental studies. Carcinogenesis 2016 0.75
341 Failure to detect prostate cancer in the PSA era: comments on N Engl J Med 2003; 349: 215-224 and N Engl J Med 2003; 349: 335-342. Cancer Causes Control 2004 0.75